Ann Mullally
Hematology & Oncology · Stanford, CANPI 1679563910
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (47.0%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 6 manufacturers reported payments, led by Incyte Corporation at 33.3% of the total.
Across 30 payments — averaging $793.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Incyte Corporation$8K
- Pharmaessentia USA Corporation$7K
- Janssen Research & Development, LLC$3K
- F. Hoffmann-la Roche AG$3K
- Biomarin Pharmaceutical Inc.$1K
- Genentech, Inc.$892
Across 13 payments — averaging $102,868 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Janssen Research & Development, LLC$537K
- Incyte Corporation$442K
- Johnson & Johnson$358K
What the payments were for
- Consulting fees$11,19147%
- Speaking & faculty fees$7,20030%
- Travel & lodging$5,02221%
- Food & beverage$3812%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Incyte Corporation | 15 | $7,921 |
| Pharmaessentia USA Corporation | 5 | $7,368 |
| Janssen Research & Development, LLC | 4 | $3,475 |
| F. Hoffmann-la Roche AG | 3 | $2,940 |
| Biomarin Pharmaceutical Inc. | 1 | $1,200 |
| Genentech, Inc. | 2 | $892 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BESREMI$7,340
- Non-Covered Product$2,863
How this compares
$23,795 in reported general payments places this provider in the 80th percentile of 1,363 hematology & oncology providers in California.
Other hematology & oncology in Stanford
- Sandra HorningStanford$2.5M
- Dennis SlamonLos Angeles$3.1M
- Mohammadbagher ZiariCorona$2.5M
- George YaghmourLos Angeles$1.9M
- Robert VescioWest Hollywood$1.1M
- Kevin KellyLos Angeles$894K
- Johnny ChangEncino$884K
- Nitin RohatgiSacramento$814K
- Omid HamidSanta Monica$809K
- Catherine CoombsOrange$786K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.